Pamidronate used to ameliorate post renal transplant bone loss is not associated with increased renal dysfunction.

被引：0
|
作者：
Lee, S [1 ]
Glicklich, D [1 ]
Coco, M [1 ]
机构：
[1] Montefiore Med Ctr, Albert Einstein Coll Med, Bronx, NY 10467 USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：695A / 695A
页数：1
相关论文
共 50 条
  • [1] Pamidronate used to attenuate post-renal transplant bone loss is not associated with renal dysfunction
    Lee, S
    Glicklich, D
    Coco, M
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (11) : 2870 - 2873
  • [2] Metabolic syndrome is associated with chronic renal transplant dysfunction.
    de Vries, APJ
    Bakker, SJL
    van Son, WJ
    Heide, JJHV
    The, HT
    de Jong, PE
    Gans, ROB
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 914A - 914A
  • [3] Alcohol Renal Syndrome: Alcohol Related Liver Disease for Liver Transplant is Associated with Renal Dysfunction.
    Lee, J.
    Okumura, K.
    Misawa, R.
    Sogawa, H.
    Veillette, G.
    John, D.
    Partiula, B.
    Bodin, R.
    Wolf, D. C.
    Diflo, T.
    Nishida, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 810 - 810
  • [4] Prevention of bone loss in renal transplant recipients: A prospective, randomized trial of intravenous pamidronate
    Coco, M
    Glicklich, D
    Faugere, MC
    Burris, L
    Bognar, I
    Durkin, P
    Tellis, V
    Greenstein, S
    Schechner, R
    Figueroa, K
    McDonough, P
    Wang, GD
    Malluche, H
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (10): : 2669 - 2676
  • [5] Increased lipoproteins and fibrinogen in chronic renal allograft dysfunction.
    Fernández-Miranda, C
    de Bustillo, EM
    Morales, JM
    Porres, A
    Gomez-Gerique, J
    Guijarro, C
    Aranda, JL
    Andrés, A
    Rodicio, JL
    Del Palacio, A
    KIDNEY INTERNATIONAL, 1999, 55 (01) : 374 - 374
  • [6] Endothelial Dysfunction Is Associated With Graft Loss in Renal Transplant Recipients
    Dahle, Dag Olav
    Midtvedt, Karsten
    Hartmann, Anders
    Jenssen, Trond
    Holdaas, Hallvard
    Mjoen, Geir
    Leivestad, Torbjorn
    Asberg, Anders
    TRANSPLANTATION, 2013, 95 (05) : 733 - 739
  • [7] The significance of luminex testing in renal transplant recipients with allograft dysfunction.
    Qazi, Yasir A.
    Cicciarelli, James
    Hermes, Mark
    Smogorzewski, Miroslaxv
    Koss, Michael
    Sher, Linda
    Selby, Robert R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 355 - 355
  • [8] Intra-operative aprotinin in liver transplant and renal dysfunction.
    Harris, Matt T.
    Holl, Pat L.
    Bennett, Kyla M.
    Collins, Brad H.
    Marroquin, Carlos E.
    Scarborough, John E.
    Tuttle-Newhall, Janet E.
    Kuo, Paul C.
    Desai, Dev M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 473 - 474
  • [9] Pamidronate therapy as prevention of bone loss following renal transplantation
    Fan, SLS
    Almond, MK
    Ball, E
    Evans, K
    Cunningham, J
    KIDNEY INTERNATIONAL, 2000, 57 (02) : 684 - 690
  • [10] C1q Dominant Deposits in Renal Transplant Biopsies Are Not Associated with Allograft Dysfunction.
    Babu, A.
    Williamson, S.
    Khoury, N.
    Safwan, M.
    Patel, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 892 - 892
12345